Israel - English - Ministry of Health

medison pharma ltd - pasireotide as diaspartate - solution for injection - pasireotide as diaspartate 0.9 mg/ml - pasireotide - pasireotide - treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.

Singapore - English - HSA (Health Sciences Authority)

pharm-d singapore private limited - pasireotide diaspartate 0.37621mg eqv. pasireotide - injection, solution - 0.3mg - pasireotide diaspartate 0.37621mg eqv. pasireotide 0.3mg

Singapore - English - HSA (Health Sciences Authority)

pharm-d singapore private limited - pasireotide diaspartate 0.75242mg eqv. pasireotide - injection, solution - 0.6 mg - pasireotide diaspartate 0.75242mg eqv. pasireotide 0.6 mg

Singapore - English - HSA (Health Sciences Authority)

pharm-d singapore private limited - pasireotide diaspartate 1.12863mg eqv. pasireotide - injection, solution - 0.9 mg - pasireotide diaspartate 1.12863mg eqv. pasireotide 0.9 mg

European Union - English - EMA (European Medicines Agency)

recordati rare diseases - pasireotide - acromegaly; pituitary acth hypersecretion - pituitary and hypothalamic hormones and analogues - signifor is indicated for the treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.signifor is indicated for the treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 300microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 600microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 900microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide pamoate - powder and solvent for suspension for injection - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide pamoate - powder and solvent for suspension for injection - 40mg